Evidence map›Paper›PMID 32443693›Full record

ArticleMolecules (Basel, Switzerland)2020

Plectrabarbene, a New Abietane Diterpene from

Nawal M Al Musayeib, Musarat Amina, Gadah Abdulaziz Al-Hamoud, Gamal A Mohamed, Sabrin R M Ibrahim, Samah Shabana

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Ethnopharmacological Validation of SelectedPlants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Bioactive Properties of Extracts fromMolecules (Basel, Switzerland) · 2022
    Article
  4. Biologically Active Diterpenoids in theInternational journal of molecular sciences · 2022
    Review
  5. Article
  6. Abietane Diterpenes of the GenusMolecules (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Preliminary Biological Activity Screening ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Nawal M Al MusayeibDepartment of Pharmacognosy, Pharmacy College, King Saud University, Riyadh 11451, Saudi Arabia.
Musarat AminaDepartment of Pharmacognosy, Pharmacy College, King Saud University, Riyadh 11451, Saudi Arabia.
Gadah Abdulaziz Al-HamoudDepartment of Pharmacognosy, Pharmacy College, King Saud University, Riyadh 11451, Saudi Arabia.
Gamal A MohamedDepartment of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-2971-6008
Sabrin R M IbrahimDepartment of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.ORCID 0000-0002-6858-7560
Samah ShabanaFaculty of Pharmaceutical Sciences and Drug Manufacturing, Pharmacognosy Department, Misr University for Science and Technology (MUST), 12511 Giza, Egypt.
King Saud University · SAAl-Azhar University · EGAssiut University · EGMisr University for Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new abietane diterpene namely plectrabarbene (

Indexed as

AbietanesCholinesterase InhibitorsDiterpenesHumansMolecular Docking SimulationMolecular StructurePlant Components, AerialPlant ExtractsPlectranthus11,14-dihydroxy-8,11,13-abietatrien-7-oneAbietanesCholinesterase InhibitorsDiterpenesPlant Extractssugiolabietane diterpeneacetylcholinesterase inhibitionLabiataemolecular dockingplectrabarbenePlectranthus barbatus

Identifiers

PMID32443693
PMCPMC7288077
OpenAlexW3027998566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.